Home › Funds › ROYCE & ASSOCIATES LP › TECH
ROYCE & ASSOCIATES LP position in TECH
BIO-TECHNE CORP · Health Care
ROYCE & ASSOCIATES LP reported holding 789,745 shares of TECH (BIO-TECHNE CORP) in its Q2 2026 13F filing — a position valued at US$55.8M, representing 0.45% of its reported portfolio and ranking #39 among its reported holdings. ROYCE & ASSOCIATES LP has disclosed TECH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ROYCE & ASSOCIATES LP's TECH position evolved
ROYCE & ASSOCIATES LP first disclosed a stake in TECH in Q3 2023 at 674,285 shares (US$45.9M). The position peaked in Q3 2024 at 845,398 shares, worth US$67.6M. Across 12 filings, ROYCE & ASSOCIATES LP increased the stake 9 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 789,745 shares valued at US$55.8M — an increase of 30,033 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 674.28K | $45.90M | New |
| Q4 2023 | 683.47K | $52.74M | Add |
| Q1 2024 | 796.56K | $56.07M | Add |
| Q2 2024 | 828.10K | $59.33M | Add |
| Q3 2024 | 845.40K | $67.57M | Add |
| Q4 2024 | 860.75K | $62.00M | Add |
| Q1 2025 | 870.18K | $51.02M | Add |
| Q2 2025 | 870.89K | $44.81M | Hold |
| Q3 2025 | 660.03K | $36.72M | Reduce |
| Q4 2025 | 678.50K | $39.90M | Add |
| Q1 2026 | 759.71K | $39.70M | Add |
| Q2 2026 | 789.75K | $55.80M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TECH and 13F data
TECH (BIO-TECHNE CORP) is a Health Care company. 29 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$482.2M), Ruane Cunniff & Goldfarb (Sequoia) (US$236.6M), SNYDER CAPITAL MANAGEMENT L P (US$223.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TECH
- HBK INVESTMENTS L P 6.83M sh · $482.19M · Q2 2026
- Ruane Cunniff & Goldfarb (Sequoia) 3.35M sh · $236.60M · Q2 2026
- SNYDER CAPITAL MANAGEMENT L P 3.16M sh · $223.52M · Q2 2026
- MAIRS & POWER INC 2.70M sh · $190.80M · Q2 2026
- WHITEBOX ADVISORS LLC 2.10M sh · $148.37M · Q2 2026
- RGM Capital, LLC 2.15M sh · $126.56M · Q4 2025
More on ROYCE & ASSOCIATES LP
FAQ
How long has ROYCE & ASSOCIATES LP held TECH?
ROYCE & ASSOCIATES LP has disclosed TECH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is ROYCE & ASSOCIATES LP's current position in TECH?
As of Q2 2026, ROYCE & ASSOCIATES LP holds 789.75K shares of TECH (BIO-TECHNE CORP), valued at $55.80M, representing 0.45% of its reported portfolio and ranking #39.
Has ROYCE & ASSOCIATES LP been buying or selling TECH?
In the latest 13F filing (Q2 2026), ROYCE & ASSOCIATES LP increased its position in TECH. The position peaked in Q3 2024 at 845.40K shares.
Which other funds hold TECH?
Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb (Sequoia), SNYDER CAPITAL MANAGEMENT L P, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.